Article Test

Home  >  Medical Research Archives  >  Issue 149  > «Long COVID» Molecular Genetic Markers in Patients with Type 2 Diabetes Mellitus
Published in the Medical Research Archives
Jul 2022 Issue

«Long COVID» Molecular Genetic Markers in Patients with Type 2 Diabetes Mellitus

Published on Jul 31, 2022

DOI 

Abstract

 

Coronavirus infection influences on multiple organs and contributes to the progression of concurrent diseases. The most notable and outstanding changes and COVID complications appear in patients with pre – existing cardiovascular and metabolic disturbances especially in elderly. There is evidence that acute viral as well as chronical diseases promote rapid cell senescence and prolong the process of recovery from disease. This review reflects the main common points and axis joining the pre-existing diseases and coronavirus infections complications and resolution. Diabetes mellitus type 2 and cardiovascular diseases (hypertension) predispose to severe outcome of the disease and the COVID-19 mortality risk. The Klotho protein level may be promising predictor of COVID severity and complications in many patients. In order to control properly the rehabilitation process and estimate the level of treatment efficacy we tried to reflect the property of milestone clue biomarker of senescence and cell damage – Klotho protein.

Author info

Aleksandr Urakov, Yulia Sorokina, Lubov Lovtsova

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?